FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094357 [Registered on: 08/09/2025] Trial Registered Prospectively
Last Modified On: 04/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study to compare two Ayurvedic nasal therapies (Kumkumadi Ghrita Nasya and Shalparni Swaras Nasya) in patients with Migraine (Ardhavbhedaka) 
Scientific Title of Study   Comparative Clinical Evaluation Of Kumkumadi Ghrita Nasya And Shalparni Swaras Nasya In Ardhavbhedaka (Migraine) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ananya Singh 
Designation  PG Scholar 
Affiliation  Patanjali Ayurvigyan Evam Anusandhan Sansthan, Haridwar 
Address  OPD 3, Department of Shalakya Tantra, Patanjali Ayurveda Hospital, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar,Uttarakhand

Hardwar
UTTARANCHAL
249405
India 
Phone  8787029307  
Fax    
Email  singhananya3011@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amit Kumar Agrawal 
Designation  Associate Professor  
Affiliation  Patanjali Ayurvigyan Evam Anusandhan Sansthan, Haridwar 
Address  OPD 3, Department of Shalakya Tantra, Patanjali Ayurveda Hospital, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar,Uttarakhand

Hardwar
UTTARANCHAL
249405
India 
Phone  9411551545  
Fax    
Email  agrawal.amitkumar308@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ananya Singh 
Designation  PG Scholar 
Affiliation  Patanjali Ayurvigyan Evam Anusandhan Sansthan, Haridwar 
Address  OPD 3, Department of Shalakya Tantra, Patanjali Ayurveda Hospital, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar,Uttarakhand

Hardwar
UTTARANCHAL
249405
India 
Phone  8787029307  
Fax    
Email  singhananya3011@gmail.com  
 
Source of Monetary or Material Support  
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan , Haridwar, Uttarakhand, India 249405 
 
Primary Sponsor  
Name  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar 
Address  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan , Haridwar, Uttarakhand,India 249405 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ananya Singh  Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar  OPD 3, Department of Shalakya Tantra, Patanjali Ayurveda Hospital, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar,Uttarakhand
Hardwar
UTTARANCHAL 
8787029307

singhananya3011@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G439||Migraine, unspecified. Ayurveda Condition: ARDHAVABEDAKAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-nasyam/ nastam, नस्यम्/ नस्तम् (Procedure Reference: Ch.Si. 89 /92, Procedure details: Poorva Karma -Abhyang with luke warm Til Taila will be done over Urdhwanga. Mridu Swedana will be given after covering the eyes with cotton swab. Pradhan Karma- The selected dose of Shalparni Swaras Nasya will be administered in each nostril. patient is asked to inhale deeply. Paschat Karma - Kavala with sukhoshna jal will be done. )
(1) Medicine Name: Shalparni Swaras Nasya , Reference: vangsen ,shiro rog, chikitsa sar sangrah 102, Route: Nasal, Dosage Form: Swaras/ Juice, Dose: 6(drops), Frequency: od, Duration: 14 Days
2Comparator ArmProcedure-nasyam/ nastam, नस्यम्/ नस्तम् (Procedure Reference: Ch.Si. 89 /92, Procedure details: Poorva Karma -Abhyang with luke warm Til Taila will be done over Urdhwanga. Mridu Swedana will be given after covering the eyes with cotton swab. Pradhan Karma- The selected dose of Kumkumadi Ghrita Nasya will be administered in each nostril. patient is asked to inhale deeply. Paschat Karma - Kavala with sukhoshna jal will be done.)
(1) Medicine Name: Kumkumadi Ghrita Nasya, Reference: Shadangdhar Samhita, 3 khand , 8 Adhay 32,33, Route: Nasal, Dosage Form: Ghrita, Dose: 6(drops), Frequency: od, Duration: 14 Days
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients with classical signs & symptoms of Ardhavabhedaka (Migraine) described as per Ayurvedic and modern science.
2. Patients between the age group of 16 years to 60 years of either sex.
3. Patients in related group who are fit for Nasya Karma / Nasya yogya vyakti. 
 
ExclusionCriteria 
Details  1. Patients less than 16 years and above 60 years of age.
2. Patients who are contraindicated for Nasya Karma.
3. Patients suffering from cluster headache, tension type of headache, sinus headache, and arising due to Meningitis ,Encephalitis, and Ocular manifestations.
4. Patient suffering from any systemic diseases like diabetes mellitus, heart disease, hypertension, cancer and receiving medication which may alter the results of study. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Assessment will be done on the basis of subjective parameters
Intensity of Headache
Frequency of headache
Duration of Headache
Nausea
Vomiting
Vertigo
Aura 
Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).  
 
Secondary Outcome  
Outcome  TimePoints 
Assessment will be done on the basis of subjective parameters   Baseline (before treatment); Mid-treatment follow-up (Day 15); End of treatment (Day 21, primary time point).  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   16/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   in this trial , we are selecting the patients of Ardhavbhedaka in which we will do the intervention in two groups (30 patients in each group).
 In the group , we will intervene with ayurvedic procedure of nasya with Kumkumadi Ghrit Nasya for 14 days ,
 whereas in other group, we will intervene with ayurvedic procedure of nasya with Shalparni Swara Nasya for 14 days .
Assessment should be done on the basis of Subjective parameters and investigations done during pre-treatment and post treatment as discussed earlier.

 
Close